Propanc Biopharma Inc (PPCB)

[elkhunter]

Mr. Nathanielsz's annual base salary is almost the companies current total market cap (excluding the cash bonus.)

On March 16, 2018, the Board of Directors (the "Board") of Propanc Biopharma, Inc. (the "Company") approved an increase of AU$100,000 (US$77,328.33) in the annual base salary of James Nathanielsz, the Company's Chief Executive Officer, from AU$300,000 (US$231,984.99) to AU$400,000 (US$309,313.32), effective immediately. In addition, having reviewed the Company's corporate objectives and performance criteria, including performance goals for Mr. Nathanielsz, the Board awarded a cash bonus of AU$300,000 (US$231,984.99) to Mr. Nathanielsz, which is equal to 100% of his annual base salary in 2017, and is consistent with the bonus parameters set forth in Mr. Nathanielsz's existing employment agreement with Company.